2 COVID Stocks That Turned $100,000 Into Well Over $1 Million in 2020

How did your investments perform in 2020? Hopefully, quite well.

Last year turned out to be an easy one for investors to make money. The S&P 500 index jumped 16%. If you bought stocks during the market meltdown in March or shortly afterward, you could have enjoyed exceptionally strong returns.

But exceptionally strong returns doesn't begin to describe what two COVID stocks delivered last year. Initial investments of $100,000 in Novavax (NASDAQ: NVAX) and Vaxart (NASDAQ: VXRT) would have grown to well over $1 million in 2020 -- nearly $2.8 million for Novavax and close to $1.7 million for Vaxart. 

Continue reading

Source Fool.com